Raphael Pharmaceutical Inc. (RAPH OTCQB) stock market data APIs
$1.4125
0(0%)
as of June 5, 2026
Try our APIs with
free plan!
Raphael Pharmaceutical Inc. Financial Data Overview
Price chart is built with
Anychart
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. Raphael Pharmaceutical Inc., is headquartered in Jaffa, Israel.
Prev. Close
1.4125
Open
1.4125
High
1.4125
Low
1.4125
52 wk Range
0.2117-1.4
Market Cap
28 247 K
Shares Outstanding
20 176 K
EPS
-0.0114
Beta
1.853
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Raphael Pharmaceutical Inc. data using free add-ons & libraries
Get Raphael Pharmaceutical Inc. Fundamental Data
Raphael Pharmaceutical Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Raphael Pharmaceutical Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Raphael Pharmaceutical Inc. News
New
Markel Insurance appoints Raphael Da Costa to lead U.S. cyber and tech E&O portfolio
RICHMOND, Va., May 7, 2026 /PRNewswire/ -- Markel, the insurance operations within Markel Group Inc. (NYSE: MKL), announced today the appointment of Raphael Da Costa to lead its U.S. cyber and tech E&...
Markel Insurance appoints Raphael Da Costa to lead U.S. cyber and tech E&O portfolio
RICHMOND, Va., May 7, 2026 /PRNewswire/ -- Markel, the insurance operations within Markel Group Inc. (NYSE: MKL), announced today the appointment of Raphael Da Costa to lead its U.S. cyber and tech E&...
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innova...
Get Raphael Pharmaceutical Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
